Amyotrophic Lateral Sclerosis (ALS) otherwise known as Lou Gehrig’s Disease or Motor Neuron Disease (MND) is a fatal, rapidly progressive neuromuscular disease that affects approximately 3,000 Canadians and more than 430 Manitobans.
U of M PhD student and ALSMB board member Nitesh Sanghai wins Mitacs Innovation Award for developing a promising new ALS drug candidate, Borsantrazole.
Thank You, Winnipeg! What an incredible day at Assiniboine Park—and what an amazing turnout! Nearly 1,000 people joined us for the Walk to End ALS, and we couldn’t be more grateful. Hosted by the ALS Society of Manitoba and ALS Canada, this inspiring event once again proved the strength of our community and our shared […]
Take us out to the ball game! ⚾ Join us on June 4th for the 2026 ALS/Lou Gehrig’s Night – an unforgettable evening with the Goldeyes! Cheer on the Winnipeg Goldeyes as they face off against the Sioux Falls Canaries, all while supporting the ALS Society of Manitoba. It’s a night of baseball, community, and […]
It's that time of year again - the 2025 Scottish Ceilidh! Mark the date on your calendar and plan to join us for music, dancing, silent auction & refreshments!
Sign up for our CONNECT E-Newsletter and keep up to date with the ALS community. Get the latest news and stories about research, events, programs, and services delivered right to your inbox.